Disease-A-Month
Volume 55, Issue 7 , Pages 422-438 , July 2009

Nosocomial or Hospital-acquired Infections: An Overview

References 

  1. Klevens RM, Edwards JR, Richards CL. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Pub Health Rep. 2007;122:160–166March–April
  2. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Cont. 2004;32:470–485
  3. CDCNNIS system. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992-June 2003 (Issued August 2003). Am J Infect Cont. 2003;31:481–498
  4. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) Report (Data summary for 2006, issued 2007). Am J Infect Cont. 2007;35:290–301
  5. Centers for Disease Control and Prevention (CDC). Outline for health care-associated infection surveillance. http://www.cdc.gov/ncidod/dhqp/nhsn+documents.html
  6. Centers for Disease Control and Prevention (CDC). Reduction in central line associated bloodstream infection among patients in intensive care units—Pennsylvania (April 2001-March 2005). MMWR Morb Wkly Rep. 2005;54:1013–1016
  7. Institute for healthcare improvement. Saving 100,000 lives campaign. http://www.ihi.org
  8. Association for Professionals in Infection Control and epidemiology (APIC). Government advocacy. http://www.apic.org/content/navigationmenu/governmentadvocacy/mandatoryreporting/abouttheissue/about_the_issue.htm
  9. Tokars JI, Richards C, Andrus M, et al. The changing face of surveillance for health care associated infections. Clin Infect Dis. 2004;39:1347–1352
  10. American Hospital Association, Hospital Statistics 2004. Chicago Health Forum LLC; 2005;
  11. Burke JP. Infection control—A problem for patient safety. N Engl J Med. 2004;348:651–656
  12. Carey AJ, Saiman L, Polin RA. Hospital Acquired Infections in the NICU: Epidemiology for the new millennium. Clin Perinatol. 2008;35:223–249
  13. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Cont. 2004;32:470–485
  14. Nguyen QV. Hospital Acquired Infections. http://www.emedicine.com/ped/fulltopic/topic1619.htm2007;August
  15. Jarvis WR. Infection control and changing health care delivery systems. Emerg Infect Dis. 2001;7(2):170–173
  16. Fauci AS. Infectious diseases: Considerations for the 21st century. Clin Infect Dis. 2001;32:675–685
  17. Trends in causes of death among the elderly. Aging Trends 1(March) 2001. Publication of the Centers for Disease Control and Prevention. Atlanta, Georgia. National Center for Health Statistics.
  18. Wenzel RP. Edmond, MB (Team based prevention of catheter related infections). N Engl J Med. 2006;355:2781–2783
  19. Kyne L. Health care associated costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346–353
  20. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health care institutions. Emerg Infect Dis. 2001;7:249–253
  21. Summary of notifiable diseases—United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;51:1–84
  22. Deaths: Leading causes for 2001. Natl Vital Stat Rep. 2003;52:Table E
  23. Scheurer DB, Hicks LS, Cook EF, et al. Short report—Accuracy of ICD-9 coding for Clostridium difficile infections: A retrospective cohort. Epidemiol Infect. 2007;135:1010–1013
  24. McFee RB. Avian influenza: The next pandemic?. Dis Mon. 2007;53:337–388
  25. 2001. Population Reference Bureau, editor. United States Government. NCHS-FASTATS-Leading Causes of Death Deaths–Leading Causes. (Data are for US for year indicated). Number of deaths for leading causes of death. http://www.cdc.gov/nchs/fastats/lcod.htm.
  26. O'Connor . diff—Rise in UK deaths (72% increase between 2005 and 2006). JC FEBS Lett. 2008;28;http://patient-health-education.suite101.com/article.cfm/c_difficile_rise_in_uk_deaths Last accessed 6/24/08
  27. Christensen M, Jepsen OB. Reduced rates of hospital acquired UTI in medical patients (Prevalence surveys indicated effect of active infection control programmes). J Hosp Infect. 2001;47:36–40
  28. Sands K, Vineyard G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis. 1996;173:963–970
  29. Manian F, Meyer L. Adjunctive use of monthly physician questionnaires for surveillance of surgical site infections after hospital discharge and in ambulatory surgical patients: Report of a seven year experience. Am J Infect Cont. 1997;25:390–394
  30. Zerey M, Paton BL, Lincourt AE, et al. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007;8(6):557–566
  31. Deaths involving MRSA and Clostridium difficile continue to rise (Health statistics). Quarterly Spring. 2007;22;Issued by the Office on National Statistics: Lond SW;1V:2QQ. http://www.statistics.gov.uk/releases
  32. Griffin FA. Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections. Jt Comm J Qual Patient Safety/JCAHO. 2007;33(12):726–731
  33. Fordtran JS. Colitis due to Clostridium difficile toxins: Underdiagnosed, highly virulent, and nosocomial. Proc Bayl Univ Med Cent. 2006;19:3–12
  34. Dramatic rise in C diff deaths. BBC News. 2008;34;February 28, http://news.bbc.co.uk/1/hi/health/7268578.stm. Last accessed 8/12/08
  35. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: New challenges from an established pathogen. Cleve Clin J Med. 2006;73(2):187–197
  36. Friedenberg FK. Clostridium difficile associated disease: Changing epidemiology and treatment options (Medscape gastroenterology 36). http://www.medscape.com/viewarticle/563386_printLast accessed 6/25/08
  37. Ashu NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors and molecular epidemiology of antibiotic associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44:2785–2791
  38. Kuijper EJ, Coignard TP. Emergence of Clostridium difficile associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6):2–18
  39. McDonald LC, Kilgore GE, Thomson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–2441
  40. Best practices document for the management of Clostridium difficile in all health care settings. Provincial Infectious Diseases Advisory Committee (PIDAC). Ministry of Health and Long Term Care. Published December 2004, Revised, November 2007.
  41. Isada CM, Kasten BL. Clostridium difficile. In: Infectious Diseases Handbook. 5th ed.. Hudson, OH: Lexi-Comp; 2003;p. 83–86
  42. Johal SS, Hammond J, Solomon K, et al. Clostridium difficile associated diarrhea in hospitalized patients: Onset in the community and hospital and role of flexible sigmoidoscopy. Gut. 2004;53:673–677
  43. Halsey J. Current and future treatment modalities for Clostridium difficile associated disease. Am J Health Syst Pharm. 2008;65:705–715
  44. Drudy D, Harnedy N, Fanning S, et al. Emergence and control of fluoroquinolone resistant, toxin A negative, toxin B positive Clostridium difficile. Infect Cont Hosp Epidemiol. 2007;28(8):932–940
  45. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics. 2008;122:1266–1270
  46. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect. 2005;60:40–45
  47. Klavs J, Bufon Luznik T, Skerl M, et al. Prevalence of and risk factors for hospital-acquired infections in Slovenia—Results of the first national survey, 2001. J Hosp Infect. 2003;54:149–157
  48. Starakis J, Marangos M, Gikas A, et al. Repeated point prevalence survey of nosocomial infections in a Greek University Hospital. J Chemother. 2002;14:272–278
  49. Dunn PM, Semmelweis I. Of Budapest and the prevention of puerperal fever. Arch Dis Child Fetal Neonatal Ed. 2005;90(4):F345–F348
  50. Taisuke H, Kawaoka Y. Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005;3:591–600
  51. Centers for Disease Control and Prevention. Deaths—Leading causes. http://www.cdc.gov/nchs/fastats/lcod.htmAccessed May 28, 2006
  52. Zigmund J. No more room; overcrowding blamed for ambulance diversions http://Modernhealthcare.com. Available at: http://www.modernhealthcare.com/printwindow.cms?articleId=38689&pageType=article.
  53. Guideline for hand hygiene in Health Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force (A report of the CDC). Morb Mortal Wkly Rep. 2002;51:RR-16
  54. Langmuir AD. Changing concepts of airborne infection of acute contagious diseases: A reconsideration of classic epidemiologic theories. Ann NY Acad Sci. 1980;353:35–44
  55. McFee RB. Preparing for an era of weapons of mass destruction (WMD): Are we there yet? (Why we should all be concerned. Part I). Vet Human Toxicol. 2002;44:193–199
  56. Smith SM. Where have you been? (The potential to overlook imported disease in the acute setting). Eur J Emerg Med. 2005;12:230–233
  57. Madren LK, Shipman C, Hayden FG. In vitro inhibitory effects of combinations of anti-influenza agents. Antivir Chem Chemother. 1995;6:109–1132005;12:230-3
  58. Aronson NE, Sanders JW, Moran KA. In harm's way: Infections in deployed American military Forces. Clin Infect Dis. 2006;43:1045–1051
  59. Centers for Disease Control and Prevention. Acinetobacter baumanii infections among patients at military medical facilities treating injured US service members 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;53:1063–1066
  60. Joint Commission Accreditation Healthcare Organizations. http://www.jointcommission.org/
  61. Cunningham R, Dial S. Is over use of proton pump inhibitors fueling the current epidemic of Clostridium difficile associated diarrhea?. J Hosp Infect. 2008;70:1–6
  62. Aseeri M, Schroeder T, Kramer J, et al. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103:2308–2313
  63. Akhtar AJ, Shaheen M. Increasing incidence of Clostridium difficile associated diarrhea in African American and Hispanic patients: Association with the use of proton pump inhibitor therapy. J Natl Med Assoc. 2007;99:500–504
  64. Creedon SA. Healthcare workers' hand decontamination practices: Compliance with recommended guidelines. J Adv Nurs. 2005;51:208–216
  65. Boyce JM. Hand hygiene compliance monitoring: Current perspectives from the USA. J Hosp Infect. 2008;70(Suppl 1):2–7
  66. Cohen MB. Clostridium difficile infections: emerging epidemiology and new treatments. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 2):S63–S65
  67. Yuen KY, Wong SSY. Human infection by avian influenza A H5N1. Hong Kong Med J. 2005;11:189–199
  68. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374–1385
  69. US Department of Health and Human Services. http://www.pandemicflu.gov/vaccine
  70. World Health Organization, WHO. Interim guidelines on clinical management of humans infected by influenza A (H5N1). http://www.who.int/csr/disease/avian_influenza/guidelines/Guidelines_Clinical%20Management_H5N1_rev.pdf
  71. McFee RB. Gulf War servicemen and servicewomen: The long road home and the role of health care professionals to enhance the troop's health and healing. Dis Mon. 2008;54:257–336
  72. Centers for Disease Control and Prevention. Overview of drug resistant acinetobacter infections in healthcare settings. http://www.cdc.gov/ncidod/dhqp/ar_acinetobacter.htmlReleased September 24, 2004
  73. Frattarelli DA, Reed MD, Giacoia GP, et al. Antifungals in systemic neonatal candidiasis. Drugs. 2004;64:949–968
  74. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356:2483–2495
  75. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660–1666
  76. Moss L. Hospital C difficile deaths: The patients let down by those they trusted. http://news.scotsman.com/latestnews/-Hospital-c-difficile-deaths.4370831.jpAccessed August 12, 2008

PII: S0011-5029(09)00047-9

doi: 10.1016/j.disamonth.2009.03.014

Disease-A-Month
Volume 55, Issue 7 , Pages 422-438 , July 2009

Article Tools